BioMarin Pharmaceutical (BMRN) Wānana Kūʻai Kūʻai
Hōʻoia AI: BMRN
Hoʻopuka ka AI i kahi kumukūʻai pahuhopu no ka lā kālepa aʻe, ka hopena pule a me ka hopena mahina. Hoʻomākaukau ʻia ka hoʻololi mai ka kumukūʻai hou loa. He helnau kūlana helu wale nō kēia, ʻaʻole he ʻōlelo aʻoaʻo hoʻopukapuka.
Kumukūʻai ma luna o nā mahina 6 i hala
Hōʻike ʻo Premium i nā pahuhopu kumukūʻai o ka AI no 1 lā, 1 pule a me 1 mahina no kēia a me nā stock ʻē aʻe.
Wehe iā Premium🔒 Moʻolelo hōʻike wānana
The forecast track record — every past forecast next to the actual close — is part of Premium.
Wehe iā PremiumE pili ana i kēia Hui
BioMarin Pharmaceutical Inc. develops and markets therapeutic enzyme products. The company has applied its proprietary enzyme technology to develop treatments for lysosomal storage diseases and serious burns. BioMarin Pharmaceutical also provides analytical and diagnostic products and services in the field of carbohydrate biology.
